CNS Pharmaceuticals, Inc. (CNSP)
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$15.9M
- Total assets
- $8.6M
- Market cap
- $7.3M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $16.0M
- Operating income
- -$16.0M
- Income tax
- $0
- Net income
- -$15.9M
- EPS (basic)
- $-35.75
- EPS (diluted)
- $-35.75
Balance sheet
- Total assets
- $8.6M
- Current assets
- $8.1M
- Total liabilities
- $4.1M
- Current liabilities
- $4.1M
- Shareholders’ equity
- $4.5M
Cash flow
- Operating cash flow
- -$13.8M
- Investing cash flow
- -$18.2K
- Financing cash flow
- $14.6M
- Net cash flow
- $739.6K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.3M
- EPS (diluted)
- $-35.75
- Shares outstanding
- 1.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 8, 2019
CNS Pharmaceuticals, Inc. (CNSP) Stock Price
- Reported a net loss of $15.9M.
- Trading 54% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review CNS Pharmaceuticals, Inc..
Write a review
News about CNS Pharmaceuticals, Inc.
News & sentiment via Polygon.io
CNS Pharmaceuticals, Inc.: frequently asked questions
Is CNS Pharmaceuticals, Inc. an American company?
CNS Pharmaceuticals, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CNS Pharmaceuticals, Inc. headquartered?
CNS Pharmaceuticals, Inc. is headquartered in Houston, Texas, United States.
Is CNS Pharmaceuticals, Inc. publicly traded?
Yes — CNS Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol CNSP on the NASDAQ.
What does CNS Pharmaceuticals, Inc. do?
CNS Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
